Multiple Antigenic Peptide (MAP) Synthesis

Multiple Antigenic Peptide (MAP) Synthesis

Custom MAP peptides, branched lysine-core peptides, peptide dendrimers, dendrons, and multi-epitope peptide immunogens for antibody production and vaccine research.

LifeTein provides custom multiple antigenic peptide (MAP) synthesis services for researchers who need high-density peptide antigens without traditional carrier-protein conjugation. MAP peptides are branched peptide constructs, typically built on a lysine-based core, that display multiple copies of the same or different peptide epitope.

MAP designs are widely used for polyclonal antibody production, peptide vaccine research, epitope presentation, immune-response studies, diagnostic assay development, and peptide-protein interaction studies.

What Are Multiple Antigenic Peptides?

Multiple Antigenic Peptides, or MAPs, are dendritic peptide structures in which several peptide chains are attached to a branched lysine scaffold. A typical MAP contains four or eight copies of a peptide epitope displayed from a central lysine core.

This multivalent structure increases the apparent molecular weight and antigen density of the peptide immunogen. Because the peptide epitope represents a high percentage of the final MAP molecule, MAPs can often stimulate antibody production without requiring KLH, BSA, or another carrier protein.

MAP Peptide Formats

MAP-4

Four copies of one peptide epitope

Commonly used for antibody production; often preferred for longer epitopes

MAP-8

Eight copies of one peptide epitope

Higher epitope density; often useful for shorter epitopes

Multi-epitope MAP

Different peptide epitopes on one branched scaffold

Useful for vaccine research or multi-site antibody studies

Lipidated MAP

MAP with lipid or palmitic acid modification

Can support immune presentation or self-assembly studies

MAP-conjugate

MAP linked to oligo, dye, biotin, or other cargo

Used for specialized detection, delivery, or binding assays

When to Choose MAP-4 vs. MAP-8

The best MAP design depends on epitope length, solubility, synthesis difficulty, and intended application.

MAP-4: often recommended for longer peptide epitopes, such as peptides above 15–20 amino acids.

MAP-8: often used for shorter epitopes where higher antigen density is desired.

Long or hydrophobic epitopes: may require MAP-4, spacer design, or an alternative conjugation strategy to reduce aggregation.

Multi-epitope designs: may require custom branch planning and analytical review.

LifeTein can help evaluate whether MAP-4, MAP-8, KLH conjugation, or another peptide antigen format is best for your antibody project.

MAP Peptides for Antibody Production

MAP peptides are popular for antibody production because they present multiple copies of the antigenic peptide in one molecule. This high epitope density can improve immune recognition and avoids the need for a large carrier protein in many projects.

Advantages of MAP Peptides

High molar ratio of peptide antigen to core scaffold

No carrier protein required in many antibody-production workflows

Defined peptide loading compared with some carrier-protein conjugates

Useful for N-terminal, internal, or selected epitope regions

Can reduce immune response against unrelated carrier proteins

Can support matched control designs and multi-epitope immunogens

MAP vs. KLH-Conjugated Peptide

Carrier protein

Usually not required

Requires KLH or another carrier

Antigen density

High peptide density on lysine core

Depends on conjugation efficiency

Defined structure

More compositionally defined

More heterogeneous conjugate mixture

Best for

Peptide antibody projects, multi-copy epitope display

Very small or weakly immunogenic peptides, routine immunization

Potential limitation

Aggregation or difficult purification for some sequences

Carrier-directed immune response and conjugation variability

MAP Peptide Synthesis Strategies

MAP peptides can be synthesized by direct solid-phase peptide synthesis or by assembling purified peptide branches onto a branched core through chemical ligation. The preferred route depends on peptide length, sequence complexity, number of branches, and required purity.

Direct SPPS on a Branched Lysine Core

In the direct approach, the peptide branches are elongated from a lysine-core resin. This method is efficient and cost-effective for many MAP-4 and MAP-8 designs.

Chemical Ligation Strategy

For difficult MAPs, especially those with long, hydrophobic, or complex peptide branches, chemical ligation can improve control over product quality. In this approach, peptide branches are synthesized and purified first, then assembled onto the branched scaffold.

Technical Challenges in MAP Synthesis

MAP peptides are more challenging than standard linear peptides because multiple peptide chains are synthesized or assembled on one scaffold. As the branches grow, steric crowding and aggregation can reduce coupling efficiency and increase deletion products.

LifeTein evaluates MAP peptide projects for:

Branch number and core structure

Epitope length and hydrophobicity

Net charge and solubility

Risk of aggregation during synthesis or purification

Need for spacer residues between the core and epitope

Compatibility with lipid, biotin, dye, oligo, or other modifications

Analytical confirmation by HPLC and mass spectrometry where applicable

Spacer and Design Options

A spacer can improve epitope accessibility and reduce steric hindrance between the lysine core and peptide branches. Common spacer options include:

Glycine or Gly-Gly spacers: flexible, simple spacing

Serine-containing spacers: improve hydrophilicity

Ahx spacer: aminohexanoic acid spacer for added distance

PEG spacer: improves flexibility and may improve solubility

Palmitic acid or lipid modification: useful for selected immune-presentation or self-assembly designs

Peptide Dendrimers and Dendrons

In addition to classical MAP antigens, LifeTein provides peptide dendrimer and dendron synthesis services. Peptide dendrimers are branched macromolecules that can display multiple functional peptide units, charged groups, targeting ligands, or cell-penetrating sequences.

Dendrons are wedge-shaped branched structures with a single focal reactive point. They are useful when a branched peptide structure must be conjugated to another molecule, surface, nanoparticle, oligonucleotide, lipid, or protein.

Applications of Peptide Dendrimers

Multivalent peptide display

Antibody production and immunogen design

Peptide vaccine research

Cell-penetrating peptide systems

DNA/RNA interaction or delivery studies

Targeting ligand display, such as RGD, TAT, GLP-1, or lipid-modified peptides

Self-assembly and micelle-like peptide systems

Published Examples Using LifeTein MAP Peptides

LifeTein MAP peptides have been used in published antibody and immunology research. Recent studies continue to use MAP-4 systems because they can present multiple copies of a peptide epitope without requiring a carrier protein.

In a 2025 Molecular Psychiatry study, peptides were synthesized by LifeTein as MAPs with four copies of the same peptide epitope on a lysine-based MAP-4 core; the authors noted that this design does not require a carrier protein because dense epitope packing and a high molar ratio can produce a strong immunological response.

In a 2018 Molecular Psychiatry study, peptides were synthesized as MAPs, where four copies of the same peptide epitope were synthesized on a lysine-based MAP-4 system by LifeTein.

MAP vaccine designs remain active in current research. For example, a 2026 npj Vaccines study tested MAP vaccines displaying four copies of a conserved bacterial epitope with or without a Cathepsin S cleavage site.

Request a MAP Peptide Quote

Please send your peptide epitope sequence, desired MAP format, branch number, spacer preference, purity, quantity, and application. For antibody production, please also tell us the target species, immunization plan, and whether you need matched linear or control peptides.

Recommended information: peptide epitope sequence, MAP-4 or MAP-8 preference, spacer, N/C-terminal requirements, purity, quantity

Optional modifications: biotin, lipid, fluorescent dye, oligo conjugation, phosphorylation, or other PTMs

Controls: linear peptide, scrambled peptide, unrelated MAP, or carrier-conjugated comparison peptide

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. You can accept all cookies or continue with essential cookies only. See our Cookie Policy.